345 related articles for article (PubMed ID: 20228816)
21. Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.
Yanamandra N; Colaco NM; Parquet NA; Buzzeo RW; Boulware D; Wright G; Perez LE; Dalton WS; Beaupre DM
Clin Cancer Res; 2006 Jan; 12(2):591-9. PubMed ID: 16428505
[TBL] [Abstract][Full Text] [Related]
22. Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation.
McMillin DW; Delmore J; Negri J; Ooi M; Klippel S; Miduturu CV; Gray NS; Richardson PG; Anderson KC; Kung AL; Mitsiades CS
PLoS One; 2011; 6(7):e20226. PubMed ID: 21750699
[TBL] [Abstract][Full Text] [Related]
23. Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells.
Weisberg E; Liu Q; Zhang X; Nelson E; Sattler M; Liu F; Nicolais M; Zhang J; Mitsiades C; Smith RW; Stone R; Galinsky I; Nonami A; Griffin JD; Gray N
PLoS One; 2013; 8(2):e56473. PubMed ID: 23437141
[TBL] [Abstract][Full Text] [Related]
24. Bioluminescence imaging correlates with tumor serum marker, organ weights, histology, and human DNA levels during treatment of orthotopic tumor xenografts with antibodies.
Poeschinger T; Renner A; Weber T; Scheuer W
Mol Imaging Biol; 2013 Feb; 15(1):28-39. PubMed ID: 22528864
[TBL] [Abstract][Full Text] [Related]
25. Liquid-based three-dimensional tumor models for cancer research and drug discovery.
Ham SL; Joshi R; Thakuri PS; Tavana H
Exp Biol Med (Maywood); 2016 May; 241(9):939-54. PubMed ID: 27072562
[TBL] [Abstract][Full Text] [Related]
26. Luminescence applications for chemotherapeutic drug development.
Andreotti PE; Caceres G; Zamkina R; Dauphinée M
Recent Results Cancer Res; 2003; 161():3-12. PubMed ID: 12528794
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.
Coleman SJ; Watt J; Arumugam P; Solaini L; Carapuca E; Ghallab M; Grose RP; Kocher HM
World J Gastroenterol; 2014 Jul; 20(26):8471-81. PubMed ID: 25024603
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma.
Kitano H; Kitadai Y; Teishima J; Yuge R; Shinmei S; Goto K; Inoue S; Hayashi T; Sentani K; Yasui W; Matsubara A
Cancer Med; 2017 Oct; 6(10):2308-2320. PubMed ID: 28834289
[TBL] [Abstract][Full Text] [Related]
29. A screening platform for glioma growth and invasion using bioluminescence imaging. Laboratory investigation.
Zhao H; Tang C; Cui K; Ang BT; Wong ST
J Neurosurg; 2009 Aug; 111(2):238-46. PubMed ID: 19199503
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis.
Niu G; Zhu L; Ho DN; Zhang F; Gao H; Quan Q; Hida N; Ozawa T; Liu G; Chen X
Theranostics; 2013; 3(3):190-200. PubMed ID: 23471295
[TBL] [Abstract][Full Text] [Related]
31. Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells.
Kuo CH; Lu YC; Tseng YS; Shi CS; Chen SH; Chen PT; Wu FL; Chang YP; Lee YR
Breast Cancer; 2014 May; 21(3):358-69. PubMed ID: 22926505
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia.
Liu P; Ma D; Yu Z; Zhe N; Ren M; Wang P; Yu M; Huang J; Fang Q; Wang J
Biomed Pharmacother; 2017 Jul; 91():21-30. PubMed ID: 28445830
[TBL] [Abstract][Full Text] [Related]
33. Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo.
Beider K; Darash-Yahana M; Blaier O; Koren-Michowitz M; Abraham M; Wald H; Wald O; Galun E; Eizenberg O; Peled A; Nagler A
Mol Cancer Ther; 2014 May; 13(5):1155-69. PubMed ID: 24502926
[TBL] [Abstract][Full Text] [Related]
34. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
35. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs.
Campana D; Manabe A; Evans WE
Leukemia; 1993 Mar; 7(3):482-8. PubMed ID: 7680404
[TBL] [Abstract][Full Text] [Related]
36. PI3K/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft.
Chen P; Wen X; Wang B; Hou D; Zou H; Yuan Q; Yang H; Xie J; Huang H
Ann Hematol; 2018 May; 97(5):865-875. PubMed ID: 29450644
[TBL] [Abstract][Full Text] [Related]
37. Functional drug screening assay reveals potential glioma therapeutics.
Badr CE; Wurdinger T; Tannous BA
Assay Drug Dev Technol; 2011 Jun; 9(3):281-9. PubMed ID: 21184646
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive bioluminescent and microPET imaging for the regulation of NF-kappaB in human hepatoma-bearing mice.
Chang TJ; Chang YJ; Ho TY; Hsiang CY; Yu CY; Lee TW; Lin WJ; Chang CH
Anticancer Res; 2009 Apr; 29(4):987-94. PubMed ID: 19414336
[TBL] [Abstract][Full Text] [Related]
39. Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer.
Xu S; Yang Z; Jin P; Yang X; Li X; Wei X; Wang Y; Long S; Zhang T; Chen G; Sun C; Ma D; Gao Q
Mol Cancer Ther; 2018 Jun; 17(6):1291-1302. PubMed ID: 29545331
[TBL] [Abstract][Full Text] [Related]
40. The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies.
Buchner M; Brantner P; Stickel N; Prinz G; Burger M; Bär C; Dierks C; Pfeifer D; Ott A; Mertelsmann R; Gribben JG; Veelken H; Zirlik K
Br J Haematol; 2010 Oct; 151(2):167-78. PubMed ID: 20738306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
